Improvement of carboplatin chemosensitivity in lung cancer cells by siRNA-mediated downregulation of DLGAP1-AS2 expression

Abstract Despite being one of the primary and most effective treatments for advanced stages of lung cancer, chemotherapy drugs like carboplatin have limitations due to their adverse side effects and the development of drug resistance in lung cancer cells. However, recent studies have shown promising...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sania Ghobadi Alamdari, Reza Mohammadzadeh, Mohammad Amini, Souzan Najafi, Behzad Baradaran, Seyedeh Zahra Bahojb Mahdavi, Amirhossein Yari, Amir Ali Mokhtarzadeh
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2025-03-01
Saila:	Scientific Reports
Gaiak:	Combination therapy Lung cancer Carboplatin Cell migration LncRNA-DLGAP1-AS2
Sarrera elektronikoa:	https://doi.org/10.1038/s41598-025-87649-6
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!